ASP Isotopes Inc. $ASPI Stock Position Raised by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in ASP Isotopes Inc. (NASDAQ:ASPI) by 7.6% during the second quarter, HoldingsChannel.com reports. The fund owned 1,348,072 shares of the company’s stock after acquiring an additional 94,751 shares during the period. Geode Capital Management LLC’s holdings in ASP Isotopes were worth $9,924,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bank of Montreal Can grew its holdings in shares of ASP Isotopes by 8.0% during the second quarter. Bank of Montreal Can now owns 27,000 shares of the company’s stock valued at $199,000 after purchasing an additional 2,000 shares during the last quarter. Rathbones Group PLC boosted its position in ASP Isotopes by 1.1% during the 2nd quarter. Rathbones Group PLC now owns 208,149 shares of the company’s stock valued at $1,532,000 after purchasing an additional 2,220 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after buying an additional 2,709 shares during the last quarter. Rhumbline Advisers grew its stake in ASP Isotopes by 8.2% during the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company’s stock worth $306,000 after buying an additional 4,963 shares during the last quarter. Finally, MetLife Investment Management LLC increased its position in ASP Isotopes by 22.1% in the first quarter. MetLife Investment Management LLC now owns 31,732 shares of the company’s stock worth $149,000 after buying an additional 5,744 shares during the period. 16.80% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at ASP Isotopes

In related news, Chairman Paul Elliot Mann sold 162,153 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $5.75, for a total transaction of $932,379.75. Following the sale, the chairman owned 7,759,538 shares of the company’s stock, valued at $44,617,343.50. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Todd Wider sold 74,108 shares of the company’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $8.76, for a total value of $649,186.08. Following the completion of the sale, the director owned 710,230 shares of the company’s stock, valued at $6,221,614.80. This trade represents a 9.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 748,352 shares of company stock worth $5,739,906 over the last ninety days. Insiders own 21.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday. Loop Capital set a $15.00 price objective on shares of ASP Isotopes in a research report on Monday, October 27th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research report on Monday, November 24th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Performance

ASPI stock opened at $5.73 on Thursday. The company has a 50-day simple moving average of $8.85 and a 200 day simple moving average of $8.78. The company has a market capitalization of $635.11 million, a P/E ratio of -4.41 and a beta of 3.41. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04. ASP Isotopes Inc. has a fifty-two week low of $3.65 and a fifty-two week high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). The company had revenue of $4.89 million for the quarter, compared to the consensus estimate of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. Sell-side analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.